Allergic Disease Onset Prevention Study

Clinical trial NCT05003804 · COMPLETED

Trial details

NCT number: NCT05003804
Sponsor: Siolta Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis Type 1 Hypersensitivity

Start date: 2021-09-01
Primary completion: 2024-11-26
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.